Skip to main content
. 2021 May 14;16(5):e0251547. doi: 10.1371/journal.pone.0251547

Fig 4.

Fig 4

(A-C) Results from the univariate sensitivity analyses, showing the ten parameters with the greatest influence on the (A) provider cost, (B) the societal costs, and the (C) effectiveness (DALYs) of the base case (Xpert). The full results for these analyses are presented S1 Text. In each one-way analysis, one parameter was varied by a factor of 10 from the mean to produce the low and high estimates, with all other parameters kept constant. Where DALYs are disability adjusted life years; Prov refers provider; and Soc is societal. DS treatment is drug-sensitive treatment. MDR refers to multi-drug resistant tuberculosis.